Fong DM - Search Results

1

Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.

Young D, Fong DM, Lawlor PA, Wu A, Mouravlev A, McRae M, Glass M, Dragunow M, During MJ. Young D, et al. Among authors: fong dm. Gene Ther. 2014 Dec;21(12):1029-40. doi: 10.1038/gt.2014.82. Epub 2014 Sep 18. Gene Ther. 2014. PMID: 25231174 Free PMC article.

2

AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.

Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B. Kells AP, et al. Among authors: fong dm. Mol Ther. 2004 May;9(5):682-8. doi: 10.1016/j.ymthe.2004.02.016. Mol Ther. 2004. PMID: 15120329 Free article.

3

AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.

Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D. Franich NR, et al. Among authors: fong dm. Mol Ther. 2008 May;16(5):947-56. doi: 10.1038/mt.2008.50. Epub 2008 Mar 25. Mol Ther. 2008. PMID: 18388917 Free PMC article.

4

Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury.

Griffin JM, Fackelmeier B, Fong DM, Mouravlev A, Young D, O'Carroll SJ. Griffin JM, et al. Among authors: fong dm. Gene Ther. 2019 May;26(5):198-210. doi: 10.1038/s41434-019-0075-6. Epub 2019 Apr 8. Gene Ther. 2019. PMID: 30962538 Free PMC article.

5

Transcriptional activity of novel ALDH1L1 promoters in the rat brain following AAV vector-mediated gene transfer.

Mudannayake JM, Mouravlev A, Fong DM, Young D. Mudannayake JM, et al. Among authors: fong dm. Mol Ther Methods Clin Dev. 2016 Nov 30;3:16075. doi: 10.1038/mtm.2016.75. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27990448 Free PMC article.

6

AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats.

Klugmann M, Symes CW, Leichtlein CB, Klaussner BK, Dunning J, Fong D, Young D, During MJ. Klugmann M, et al. Mol Cell Neurosci. 2005 Feb;28(2):347-60. doi: 10.1016/j.mcn.2004.10.002. Mol Cell Neurosci. 2005. PMID: 15691715

7

Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.

Griffin JM, Fackelmeier B, Clemett CA, Fong DM, Mouravlev A, Young D, O'Carroll SJ. Griffin JM, et al. Among authors: fong dm. Exp Neurol. 2020 May;327:113232. doi: 10.1016/j.expneurol.2020.113232. Epub 2020 Feb 7. Exp Neurol. 2020. PMID: 32044329

8

An Immunological Approach to Increase the Brain's Resilience to Insults.

Lin EJ, Symes CW, Townsend-Nicholson A, Klugmann M, Klugmann CB, Lehnert K, Fong D, Young D, During MJ. Lin EJ, et al. ISRN Neurosci. 2014 Apr 24;2014:103213. doi: 10.1155/2014/103213. eCollection 2014. ISRN Neurosci. 2014. PMID: 24967312 Free PMC article.

9

VEGF links hippocampal activity with neurogenesis, learning and memory.

Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, During MJ. Cao L, et al. Among authors: fong dm. Nat Genet. 2004 Aug;36(8):827-35. doi: 10.1038/ng1395. Epub 2004 Jul 18. Nat Genet. 2004. PMID: 15258583

10

Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis.

O'Sullivan D, Green L, Stone S, Zareie P, Kharkrang M, Fong D, Connor B, La Flamme AC. O'Sullivan D, et al. PLoS One. 2014 Aug 12;9(8):e104430. doi: 10.1371/journal.pone.0104430. eCollection 2014. PLoS One. 2014. PMID: 25116424 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters